{"version":"1.0","type":"link","title":"Efficacy and safety findings of the EXTRA study in older adult EGFR-mutant lung cancer patients receiving afatinib as first-line treatment.","author_name":"Morikawa K 외","author_url":"https://prs-insight.online/author/Morikawa%20K","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/97290","thumbnail_width":1200,"thumbnail_height":630}